Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1

22nd May 2017 Uncategorised 0

Novo Nordisk, facing more pressure than ever in the U.S., is revving up its Latin American plans for the obesity drug Saxenda, which shows particular promise in Mexico.

More: Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1
Source: fierce